Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Advaxis Inc ADXS

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s):  ADXSE | ADXSD

Advaxis Inc is a clinical development stage biotechnology company. The company is engaged in developing safe & effective immunotherapies for cancer & infectious diseases.
Price: $7.97 | Change: +$0.40 | %Change: +5.28%
Volume: 510,757 | Day High/Low: 8.01/7.17 | 52 Week High/Low: 8.01/2.46
View modes: 
0 stars

Profit on ADXS

I am thinking this is filling in this gap upbut overall still made a good signal on this.  http://pennystockformula.com/cms/blog/  rate and reply
0 stars

Advaxis, Inc. (ADXS) Participating in the Canaccord Genuity

Advaxis, Inc. (ADXS) Participating in the Canaccord Genuity Orphan Drug One-on-One Day Advaxis announced today that it will be a participant in the Canaccord Genuity Orphan Drug One-on-One Day. The...read more
0 stars

Advaxis, Inc. (ADXS) Presenting at the Bloomberg 2014 State

Advaxis, Inc. (ADXS) Presenting at the Bloomberg 2014 State of Healthcare Summit Advaxis today reported that its Chief Scientific Officer, Robert G. Petit, Ph.D. will be presenting on an expert panel...read more
0 stars

Advaxis, Inc. (ADXS) Engages SynCo Bio Partners for Manufact

Advaxis, Inc. (ADXS) Engages SynCo Bio Partners for Manufacturing of ADXS-HPV Today before the opening bell, Advaxis, a biotechnology company developing the next generation of cancer immunotherapies,...read more
0 stars

Advaxis, Inc. (ADXS) Strengthens Partnership with GRU Cancer

Advaxis, Inc. (ADXS) Strengthens Partnership with GRU Cancer Center at Georgia Regents University for Cancer Immunotherapy Trials Advaxis, a biotechnology company developing the next generation of...read more
0 stars

Advaxis, Inc. (ADXS) Presenting at the 16th Annual BIO CEO &

Advaxis, Inc. (ADXS) Presenting at the 16th Annual BIO CEO & Investor Conference Today before the opening bell, Advaxis announced that it will be presenting at the 16th Annual BIO CEO & Investor...read more
0 stars

Advaxis, Inc. (ADXS), Biocon Ltd. Ink Licensing Deal to Addr

Advaxis, Inc. (ADXS), Biocon Ltd. Ink Licensing Deal to Address Cervical Cancer in India, Asia Advaxis, a clinical-stage biotech company developing the next generation of cancer immunotherapies, has...read more
0 stars

Advaxis, Inc. (ADXS) Doses First Patient in ADXS-HPV Phase 1

Advaxis, Inc. (ADXS) Doses First Patient in ADXS-HPV Phase 1/2 Cancer Study Advaxis, a clinical-stage biotech company developing next-generation cancer immunotherapies, reports today that the first...read more
0 stars

Advaxis, Inc. (ADXS) Announces Launch of Online Communicatio

Advaxis, Inc. (ADXS) Announces Launch of Online Communications Channels Suite Advaxis, a leader in development of the next generation of cancer immunotherapies, announced today that it has launched a...read more
0 stars

Advaxis, Inc. (ADXS) Presenting at Biotech Showcase 2014

Advaxis, Inc. (ADXS) Presenting at Biotech Showcase 2014 Today before the opening bell, Advaxis announced that it will be presenting at the Biotech Showcase 2014 Conference in San Francisco...read more
0 stars

Advaxis, Inc. (ADXS) Prices Public Offering of 5.75M Shares,

Advaxis, Inc. (ADXS) Prices Public Offering of 5.75M Shares, Announces Uplisting to NASDAQ Without question, Biotech companies can generate some of the most explosive returns on Wall Street. It’s not...read more
0 stars

Advaxis, Inc. (ADXS) is Sending the Right Signals

Advaxis, Inc. (ADXS) is Sending the Right Signals Without question, Biotech companies can generate some of the most explosive returns on Wall Street. It’s not unusual to see 10 to 20 times return...read more
0 stars

Advaxis, Inc. (ADXS) Publishes Preclinical Research for HPV Treatment Candidate

Advaxis, Inc. (ADXS) Publishes Preclinical Research for HPV Treatment Candidate Today, leading developer of immunotherapies for cancer and other diseases, Advaxis, announced that it has published the...read more
0 stars

Three Abstracts from Advaxis, Inc. (ADXS) Accepted for Presentation at Society for Immunotherapy of Cancer Annual Meeting

Three Abstracts from Advaxis, Inc. (ADXS) Accepted for Presentation at Society for Immunotherapy of Cancer Annual Meeting Advaxis, a leader in developing the next generation of immunotherapies for...read more
0 stars

MissionIR Features Advaxis, Inc. (ADXS) CEO Dan O’Conner in Exclusive Interview

MissionIR Features Advaxis, Inc. (ADXS) CEO Dan O’Conner in Exclusive Interview MissionIR today announces that its interview with Dan O’Conner, the president and Chief Executive Officer of Advaxis...read more
0 stars

Advaxis, Inc. (ADXS) Reports Additions to the Executive Leadership Team

Advaxis, Inc. (ADXS) Reports Additions to the Executive Leadership Team Advaxis, a leader in developing the next generation of immunotherapies for cancer and infectious diseases, today announced the...read more
0 stars

Advaxis, Inc. (ADXS) Awarded Orphan Drug Designation for Candidate to Treat HPV-Associated Anal Cancer

Advaxis, Inc. (ADXS) Awarded Orphan Drug Designation for Candidate to Treat HPV-Associated Anal Cancer Advaxis, a clinical-stage biotech developing the next generation of immunotherapies for cancer...read more
0 stars

Advaxis, Inc. (ADXS) Partnerships Mimic Game-Changing Alliance Strategy of World’s Top Business Leaders

Advaxis, Inc. (ADXS) Partnerships Mimic Game-Changing Alliance Strategy of World’s Top Business Leaders Strong business alliances can be the foundation of success – some of the world’s leading...read more
0 stars

Advaxis, Inc. (ADXS) Offers Superior Cancer Treatment

Advaxis, Inc. (ADXS) Offers Superior Cancer Treatment Advaxis has invented an innovative immunotherapy technology for treating various cancers and other diseases. The company’s primary therapeutic...read more
0 stars

Advaxis, Inc. (ADXS) Provides Corporate Update, Program Development, Outlook for 2013

Advaxis, Inc. (ADXS) Provides Corporate Update, Program Development, Outlook for 2013 Advaxis, a clinical-stage biotech company developing the next generation of immunotherapies for cancer and...read more

Featured News Links